Drug Delivery Target Identification and Validation


Target endorsement is the leading step in discerning a new drug and can stereotypically take 2-6 months. The process embroils the tender of a range of techniques that aim to demonstrate that drug effects on the target can provide a therapeutic benefit with an acceptable safety window.  Premature in-depth target endorsement increases indulgent between target manipulation and disease efficacy, leading to increased likelihood of success in the clinic.  Once a bull has reached an adequate level of validation and disease linkage, the project moves into the hit identification phase.


    Related Conference of Drug Delivery Target Identification and Validation

    April 17-18, 2024

    14th International Conference on Chemistry Meeting

    Paris, France
    June 25-26, 2024

    13th World Congress on Chromatography

    Toronto, Canada
    August 22-23, 2024

    16th International Conference on Clinical Chemistry

    Berlin, Germany
    December 18-19, 2024

    4th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands

    Drug Delivery Target Identification and Validation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in